Journal of Histochemistry and Cytochemistry Priciples for Free Access to Science
  Search:   
    >> Advanced Search

Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Darcy, K. M.
Right arrow Articles by Ip, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Darcy, K. M.
Right arrow Articles by Ip, M. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Histochemistry and Cytochemistry, Vol. 48, 63-80, January 2000, Copyright © 2000, The Histochemical Society, Inc.

ARTICLE

Changes in ErbB2 (her-2/neu), ErbB3, and ErbB4 during Growth, Differentiation, and Apoptosis of Normal Rat Mammary Epithelial Cells

Kathleen M. Darcya, Danilo Zangania, Ann L. Wohlhuetera, Ruea-Yea Huanga, Mary M. Vaughana, Joy A. Russella, and Margot M. Ipa
a Department of Pharmacology and Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, New York

Correspondence to: Margot M. Ip, Grace Cancer Drug Center, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263. E-mail: mip@sc3101.med.buffalo.edu

Studies were undertaken to examine the natural role of ErbB2, ErbB3, and ErbB4 during the development of normal rat mammary epithelial cells (MECs) in vivo and in vitro. Immunohistochemical analysis demonstrated that mammary gland terminal end buds expressed abundant ErbB2 and ErbB4 but limited ErbB3 in pubescent rats, whereas luminal epithelial cells in nulliparous rats expressed ErbB2, ErbB3, and/or ErbB4. During pregnancy, ductal epithelial cells and stromal cells expressed abundant ErbB3 but limited ErbB2. Although ErbB2 and ErbB3 were downregulated throughout lactation, both receptors were re-expressed during involution. In contrast, ErbB4 was downregulated throughout pregnancy, lactation, and involution. Immunoblotting and immunoprecipitation studies confirmed the developmental expression of ErbB2 and ErbB3 in the mammary gland and the co-localization of distinct ErbB receptors in the mammary gland of nulliparous rats. In agreement with our in vivo findings, primary culture studies demonstrated that ErbB2 and ErbB3 were expressed in functionally immature, terminally differentiated and apoptotic MECs, and downregulated in functionally differentiated MECs. ErbB receptor signaling was required for epithelial cell growth, functional differentiation, and morphogenesis of immature MECs, and the survival of terminally differentiated MECs. Finally, ErbB4 expression did not interfere with functional differentiation and apoptosis of normal MECs. (J Histochem Cytochem 48:63–80, 2000)

Key Words: mammary, breast, ErbB2, her-2/neu, ErbB3, ErbB4, EGF receptor, immunohistochemistry, immunocytochemistry


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
M. M. Ip, S. O. McGee, P. A. Masso-Welch, C. Ip, X. Meng, L. Ou, and S. F. Shoemaker
The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium
Carcinogenesis, June 1, 2007; 28(6): 1269 - 1276.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S. Guo and G. E. Sonenshein
Forkhead Box Transcription Factor FOXO3a Regulates Estrogen Receptor Alpha Expression and Is Repressed by the Her-2/neu/Phosphatidylinositol 3-Kinase/Akt Signaling Pathway
Mol. Cell. Biol., October 1, 2004; 24(19): 8681 - 8690.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
O. Tikhomirov and G. Carpenter
Ligand-induced, p38-dependent Apoptosis in Cells Expressing High Levels of Epidermal Growth Factor Receptor and ErbB-2
J. Biol. Chem., March 26, 2004; 279(13): 12988 - 12996.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
J. C. Fleet, L. Wang, O. Vitek, B. A. Craig, and H. J. Edenberg
Gene expression profiling of Caco-2 BBe cells suggests a role for specific signaling pathways during intestinal differentiation
Physiol Genomics, March 18, 2003; 13(1): 57 - 68.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
C. Dillon, A. Creer, K. Kerr, A. Kumin, and C. Dickson
Basolateral Targeting of ERBB2 Is Dependent on a Novel Bipartite Juxtamembrane Sorting Signal but Independent of the C-Terminal ERBIN-Binding Domain
Mol. Cell. Biol., September 15, 2002; 22(18): 6553 - 6563.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Kim, M. J. Lindstrom, and M. N. Gould
Regions of H- and K-Ras That Provide Organ Specificity/Potency in Mammary Cancer Induction
Cancer Res., March 1, 2002; 62(5): 1241 - 1245.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K. Horsch, M. D. Schaller, and N. E. Hynes
The Protein Tyrosine Phosphatase-PEST Is Implicated in the Negative Regulation of Epidermal Growth Factor on PRL Signaling in Mammary Epithelial Cells
Mol. Endocrinol., December 1, 2001; 15(12): 2182 - 2196.
[Abstract] [Full Text] [PDF]



Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
The Journal of Histochemistry & Cytochemistry is owned, published, and licensed by The Histochemical Society © 2000